Advent PharmaDHA:ADVENT +2.55%29 Market Cap is BDT0.00 Mil as of Jun. 30, 2026. GuruFocus rates DHA:ADVENT with a GF Score™ of 29/100. Among 1,020 Drug Manufacturers companies, Advent Pharma ranks worse than 98039.12% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Advent Pharma's share price for the quarter that ended in . 20 was BDT. Advent Pharma's Shares Outstanding (EOP) for the quarter that ended in . 20 was 0.00 Mil. Therefore, Advent Pharma's market cap for the quarter that ended in . 20 was BDT Mil.
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Advent Pharma's Enterprise Value for Today is BDT0.00 Mil.
Advent Pharma (DHA:ADVENT) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Advent Pharma Market Cap Related Terms
Advent Pharma Market Cap Historical Data
* Premium members only.
The historical data trend for Advent Pharma's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Advent Pharma Market Cap Chart
Advent Pharma Annual Data
Trend
Market Cap
Advent Pharma Semi-Annual Data
Market Cap
DHA:ADVENT vs : Market Cap Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Advent Pharma's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Advent Pharma Market Cap vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Advent Pharma's Market Cap distribution charts can be found below:
* The bar in red indicates where Advent Pharma's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Advent Pharma's Market Cap for the fiscal year that ended in . 20 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Advent Pharma (DHA:ADVENT) has a Market Cap of BDT0.00 Mil as of Jun. 30, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Advent Pharma and its competitors. According to the industry distribution chart, Advent Pharma ranks #999999 out of 1020 companies in the Drug Manufacturers industry.
Is Advent Pharma's Market Cap too high?
Advent Pharma's current Market Cap is BDT0.00 Mil. Based on the distribution chart, Advent Pharma ranks #999999 out of 1020 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Advent Pharma has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does Advent Pharma's Market Cap compare to ?
According to the Drug Manufacturers industry distribution chart, Advent Pharma ranks #999999 out of 1020 companies for Market Cap. This places Advent Pharma in the lower half of its industry. The industry median Market Cap is 213.67. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 213.67, based on 1,020 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Advent Pharma and its competitors. For the Drug Manufacturers industry, the median Market Cap is 213.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Advent Pharma's current Market Cap is BDT0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Advent Pharma stock overvalued right now?
Advent Pharma (DHA:ADVENT) has a current Market Cap of BDT0.00 Mil. The current Market Cap is BDT0.00 Mil. Advent Pharma's overall GF Score™ is 29/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Advent Pharma (DHA:ADVENT), the current Market Cap is BDT0.00 Mil as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DHA:ADVENT has been successfully added to your 